Shanxi Zhenglai Pharmaceutical

Shanxi Zhenglai Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company specializing in the cultivation, research, development, manufacturing, and marketing of Traditional Chinese Medicine (TCM). Established in 2016 as a wholly-owned subsidiary of Zhen'ao Pharmaceutical Group, the company operates a modern, automated manufacturing facility in Pingshun County, Changzhi, Shanxi Province. Its product portfolio includes 49 drug varieties, highlighted by national exclusive products such as Ludangshen Oral Liquid, Compound Ganoderma Brain-strengthening Capsule, and Shizi Qiangshen Wine. The company's flagship product, Ludangshen Oral Liquid, is derived from local premium Codonopsis pilosula (Ludangshen) and is widely used to treat spleen and lung deficiencies, fatigue, and chronic respiratory conditions, and is included in China's National Medical Insurance Catalog.